Ordinary Adjustment | Solactive Global Big Pharma Index | Effective Date 6th February 2025
Solactive Global Big Pharma Index:
In the ordinary adjustment, the following composition will be implemented effective open 6th February 2025:
| ABBVIE INC |
| ROCHE HOLDING AG |
| ELI LILLY & CO |
| BRISTOL-MYERS SQUIBB CO |
| MERCK & CO. INC. |
| JOHNSON & JOHNSON |
| PFIZER INC |
| VERTEX PHARMACEUTICALS INC |
| GILEAD SCIENCES INC |
| AMGEN INC |
| ASTRAZENECA PLC-SPONS ADR |
| GSK PLC-SPON ADR |
| NOVO-NORDISK A/S-SPONS ADR |
| NOVARTIS AG-SPONSORED ADR |
| SANOFI-ADR |